SCHEMBL52612

SCHEMBL52612

Cn1cncc1C=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoromethanesulfonic Acid SCHEMBL4892637 0.82 SRC (0.33)
SCHEMBL27827274 0.74
SCHEMBL7493063 0.73 CYP11B1 (0.46)
SCHEMBL2763120 0.71
SCHEMBL27794088 0.71
SCHEMBL2053915 0.71 CYP11B1 (0.35)
SCHEMBL4033479 0.71 CYP11B1 (0.38)
SCHEMBL2422312 0.71
SCHEMBL2219293 0.70 TBXAS1 (0.45)
SCHEMBL2219288 0.70 TBXAS1 (0.45)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 696 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116199607-B Preparation method of pilocarpine and intermediate compound thereof 浙江奥翔药业股份有限公司 2025-02-14 CN claimed
CN-118491711-A Purification method of talcum and magnesite concentrate powder 大石桥市好镁科技有限公司 2024-08-16 CN claimed
US-11668708-B2 Method for reducing measurement error in latex agglutination immunoassay SEKISUI MEDICAL CO., LTD. (JP) 2023-06-06 US claimed
CN-116199607-A Preparation method of pilocarpine and intermediate compound thereof 浙江奥翔药业股份有限公司 2023-06-02 CN claimed
CN-107667097-B Separation of enantiomers of 3-ethylbicyclo [3.2.0] hept-3-en-6-one 诺瓦色生物公司 2021-02-12 CN claimed
CN-110124525-B Mixed matrix membrane containing imidazole ester metal organic framework material, preparation and application 华中科技大学 2020-05-19 CN claimed
EP-3303308-B1 SEPARATION OF ENANTIOMERS OF 3-ETHYLBICYCLO[3.2.0]HEPT-3-EN-6-ONE NOVASSAY SA (CH) 2019-10-09 EP claimed
US-10150723-B2 Separation of enantiomers of 3-ethylbicyclo[3.2.0]hept-3-en-6-one NOVASSAY S.A. (CH) 2018-12-11 US claimed
US-20180134643-A1 SEPARATION OF ENANTIOMERS OF 3-ETHYLBICYCLO[3.2.0]HEPT-3-EN-6-ONE NOVASSAY S.A. (CH) 2018-05-17 US claimed
EP-3303308-A1 SEPARATION OF ENANTIOMERS OF 3-ETHYLBICYCLO[3.2.0]HEPT-3-EN-6-ONE Novassay SA (CH) 2018-04-11 EP claimed
WO-2016146299-A1 SEPARATION OF ENANTIOMERS OF 3-ETHYLBICYCLO[3.2.0]HEPT-3-EN-6-ONE NOVASSAY SA (CH) 2016-09-22 WO claimed
US-4662905-A REACTION PRODUCT OF COPPER SALT AND AN IMIDAZOLE, PYRAZOLE, TRIAZOLE, OR TETRAZOLE Itaru Todoriki, Director of Agency of Industrial Science and Technology (JP) 1987-05-05 US claimed
US-20260069602-A1 COMPOUNDS, COMPOSITIONS, AND METHODS ACONCAGUA BIO INC (US) 2026-03-12 US disclosed
US-12528781-B2 Heterocyclic GLP-1 agonists GASHERBRUM BIO, INC. (US) 2026-01-20 US disclosed
US-20250333418-A1 PURINE COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USES THEREOF NOVO NORDISK AS (DK) 2025-10-30 US disclosed
US-20250304597-A1 COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 2025-10-02 US disclosed
EP-0482771-A2 Heterocyclic acids ZENECA LIMITED (GB) 1992-04-29 EP disclosed
US-5068237-A Substituted furans and derivatives thereof acting at muscarinic receptors WARNER-LAMBERT COMPANY (US) 1991-11-26 US disclosed
US-4662905-A REACTION PRODUCT OF COPPER SALT AND AN IMIDAZOLE, PYRAZOLE, TRIAZOLE, OR TETRAZOLE Itaru Todoriki, Director of Agency of Industrial Science and Technology (JP) 1987-05-05 US disclosed
EP-0091056-A3 5-SUBSTITUTED-4-METHYLIMIDAZOLES AND PROCESS FOR THEIR PREPARATION BASF Aktiengesellschaft (DE) 1985-05-02 EP disclosed